Bill Gates Donates $1.7 Million To Scientists To Help Research a Male Contraceptive Pill

Bill Gates Donates $1.7 Million To Scientists To Help Research a Male Contraceptive Pill

Bil Gates, the co-founder of Microsoft and one of the richest men alive recently showed his support for scientists that research towards creating the male contraceptive pill. To back up his words, he gave their work a huge funding boost through the Bill & Melinda Gates Foundation.

Scientists have been working on the male contraceptive pill for years, and the researchers at the University of Dundee will have a lot more to work with after they received $1.7 million from the Bil & Melinda Gates Foundation. The team plans to use the funds over the next two years.

The University of Dundee researchers had developed a miniatures parallel testing system that uses a fast microscope that can monitor the very fast movement of male reproductive liquid in a precise way and help screen the effects of the pills currently available.

Bill Gates had previously donated more than $900,000 to the university’s research three years ago, and the new donation will help the team with their important work.

This is what Chris Barratt, the Professor of Reproductive Medicine in Dundee University’s School of Medicine said of the donation:

“There has been no significant change in the field of male contraception since the development of the condom.
This means that much of the burden of protecting against unwanted pregnancies continue to fall upon women. We hope to address that inequality and we have already made progress, thanks to our previous round of funding received from the Bill & Melinda Gates Foundation.
By the end of this two-year period, we would like to have identified a high-quality compound that we can progress to the first stages of drug development.”

It’s important to note, however, that even though a lot of work has been done, there hasn’t been any mainstream and health-approved contraception options for men beyond condoms.

Source: LADBible

 
Comments
 
Comments

No comments yet.

Leave a Reply